Royalty Pharma Correlations

RPRX Stock

USD 33.70 0.20 0.60%

The correlation of Royalty Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Royalty Pharma Correlation With Market

Good diversification

The correlation between Royalty Pharma Plc and DJI is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Royalty Pharma Plc and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Royalty Pharma Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Moving together with Royalty Stock

0.86	AZN	AstraZeneca PLC ADR	Pair Corr
0.69	LLY	Eli Lilly	Pair Corr
0.79	PLX	Protalix Biotherapeutics	Pair Corr
0.87	SNY	Sanofi ADR	Pair Corr
0.77	GILD	Gilead Sciences	Pair Corr
0.74	GOSS	Gossamer Bio	Pair Corr
0.81	DRMAW	Dermata Therapeutics	Pair Corr
0.75	NVCT	Nuvectis Pharma	Pair Corr
0.87	AMGN	Amgen Inc	Pair Corr

Moving against Royalty Stock

0.95	ZURA	Zura Bio Limited	Pair Corr
0.93	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.93	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.82	ELVN	Enliven Therapeutics	Pair Corr
0.81	IMMX	Immix Biopharma	Pair Corr
0.75	CDIOW	Cardio Diagnostics	Pair Corr
0.69	INBX	Inhibrx Symbol Change	Pair Corr
0.68	GPCR	Structure Therapeutics	Pair Corr
0.64	IMRX	Immuneering Corp	Pair Corr
0.62	MRK	Merck Company	Pair Corr
0.42	ELEV	Elevation Oncology	Pair Corr
0.36	OCEAW	Ocean Biomedical	Pair Corr
0.97	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.92	CDIO	Cardio Diagnostics	Pair Corr
0.89	CGEM	Cullinan Oncology LLC	Pair Corr
0.82	ATNF	180 Life Sciences	Pair Corr
0.8	PYXS	Pyxis Oncology	Pair Corr
0.8	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.77	PMVP	Pmv Pharmaceuticals	Pair Corr
0.77	SCLX	Scilex Holding	Pair Corr
0.72	BIIB	Biogen Inc	Pair Corr
0.69	AVTE	Aerovate Therapeutics	Pair Corr
0.66	CNSP	Cns Pharmaceuticals	Pair Corr
0.64	CELC	Celcuity LLC Earnings Call This Week	Pair Corr
0.45	ADVM	Adverum Biotechnologies	Pair Corr
0.45	CMND	Clearmind Medicine Common	Pair Corr
0.38	SONN	Sonnet Biotherapeutics	Pair Corr
0.33	PHIO	Phio Pharmaceuticals Corp	Pair Corr

Related Correlations Analysis

	PRME	RPHM	DNA	OCEA	ADPT	VECT	KNTE	IKNA	ASND	APLS
PRME		0.0	0.58	0.67	-0.16	0.0	0.0	0.73	-0.48	0.75	PRME
RPHM	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RPHM
DNA	0.58	0.0		0.06	0.31	0.0	0.0	0.3	-0.61	0.39	DNA
OCEA	0.67	0.0	0.06		-0.75	0.0	0.0	0.87	-0.46	0.84	OCEA
ADPT	-0.16	0.0	0.31	-0.75		0.0	0.0	-0.64	0.29	-0.57	ADPT
VECT	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	VECT
KNTE	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	KNTE
IKNA	0.73	0.0	0.3	0.87	-0.64	0.0	0.0		-0.53	0.89	IKNA
ASND	-0.48	0.0	-0.61	-0.46	0.29	0.0	0.0	-0.53		-0.56	ASND
APLS	0.75	0.0	0.39	0.84	-0.57	0.0	0.0	0.89	-0.56		APLS
	PRME	RPHM	DNA	OCEA	ADPT	VECT	KNTE	IKNA	ASND	APLS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

APLS	+ 0.89	IKNA
IKNA	+ 0.87	OCEA
APLS	+ 0.84	OCEA
APLS	+ 0.75	PRME
IKNA	+ 0.73	PRME
OCEA	+ 0.67	PRME

High negative correlations

ADPT	- 0.75	OCEA
IKNA	- 0.64	ADPT
ASND	- 0.61	DNA
APLS	- 0.57	ADPT
APLS	- 0.56	ASND
ASND	- 0.53	IKNA

Risk-Adjusted Indicators

There is a big difference between Royalty Stock performing well and Royalty Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Royalty Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PRME	4.53	(0.24)	0.00	(0.15)	0.00	0.00	10.03	(9.28)	25.37
RPHM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
DNA	5.75	0.04	0.00	(0.05)	0.00	0.00	12.92	(9.86)	31.71
OCEA	7.12	(3.00)	0.00	(1.94)	0.00	0.00	15.38	(15.19)	51.00
ADPT	3.71	0.71	0.18	0.24	3.29	(4.93)	12.29	(5.91)	27.21
VECT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
KNTE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
IKNA	2.08	(0.23)	0.00	(0.58)	0.00	0.00	4.65	(3.73)	16.13
ASND	2.49	0.49	0.19	0.38	2.24	(2.90)	5.86	(3.90)	18.15
APLS	2.14	(0.37)	0.00	(0.43)	0.00	0.00	4.11	(4.33)	20.77

Royalty Pharma Corporate Management

Eric Schneider	Senior Officer	Profile
George Lloyd	Executive Officer	Profile
Marshall MD	Executive Investments	Profile
Sandy Balkin	Senior Analytics	Profile
Sara Klymkowsky	Senior Investments	Profile
Ashwin MD	Executive Investments	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC